Blue Sail Shanghai Innovation Center Launched at ATLATL
July 30, 2020 at 11:45 am EDT
Share
Blue Sail Medical Co.,Ltd. opened its Blue Sail Shanghai Innovation Center (BSIC) in July 2020 at ATLATL Innovation Center, which built the customized GMP facility after a 10-month effort. Blue Sail entered the cardiovascular arena after acquisition of Biosensors International Group Ltd. (abbr. Biosensors), who has been developing and distributing critical care catheter systems and related devices used during heart surgery and intensive care. They have been working on drug-eluting stents, drug-coated stents, and bare metal stents, as well as angioplasty catheters for the treatment of coronary artery disease, offering interventional devices and solutions for patients living with coronary artery disease. In the near future, Bluesail will have four product lines in the innovation center: Coronary intervention products, Structural heart products, Peripheral vascular products, and Neurovascular products. With the concept of mutual building and sharing, Blue Sail built the platform for both health protection and health care via industry investment and venture capital. Blue Sail is committed to developing a world-class leading enterprise in the comprehensive medical industry as a famous brand trusted by the public.
BLUE SAIL MEDICAL CO., LTD. is a China-based company principally engaged in the manufacture and sales of health protective gloves. The Companyâs products include medical grade PVC gloves and non-medical grade polyvinyl chloride (PVC) gloves. Through its subsidiaries, the Company is involved in the trading of PVC gloves, plastic products and others, as well as wholesale of plastic products, medical equipment and others. The Company distributes its products in domestic markets and to overseas markets.